Uremic toxins: some thoughts on acrolein and spermine

References

• Norris KC, Agoda Y. Unraveling the racial disparities associated with kidney disease. Kidney Int. 2005;68:914–924.
   PubMed Web of Science ®Google Scholar
• Gilbertson DT, Liu J, Xue JL, et al. Projecting the number of patients with end-stage renal disease in the United States to the year 2015. J Am Soc Nephrol. 2005;16:3736–3741.
   PubMed Web of Science ®Google Scholar
• USRD: Annual Data Report: Atlas of end-stage renal disease in the United States. Bethesda, MD: National Institute of Health. National Institute of Diabetes and Digestive and Kidney Diseases; 2003.
   Google Scholar
• Trivedi HS, Pang HM, Campbell A, Saab P. Slowing the progression of chronic renal failure: Economic benefits and patients’ perspectives. Am J Kidney Dis. 2002;39:721–729.
   PubMed Web of Science ®Google Scholar
• Vanholder R, Argiles A, Baurmeister U, et al. Uremic toxicity: Present state of the art. Int J Artif Organs. 2001;24:695–725.
   PubMed Web of Science ®Google Scholar
• Sallée M, Dou L, Cerini C, Poitevin S, Brunet P, Burtey S. The aryl hydrocarbon receptor-activating effect of uremic toxins from tryptophan metabolism: A new concept to understand cardiovascular complications of chronic kidney disease. Toxins (Basel). 2014;6:934–949.
   PubMed Web of Science ®Google Scholar
• Chao CT, Chiang CK. Uremic toxins, oxidative stress, and renal fibrosis: An interwined complex. J Ren Nutr. 2015;25:155–159.
   PubMed Web of Science ®Google Scholar
• Martinez AW, Recht NS, Hostetter TH, Meyer TW. Removal of P-cresol sulfate by hemodialysis. J Am Soc Nephrol. 2005;16:3430–3436.
   PubMed Web of Science ®Google Scholar
• Vanholder R, van Laecke S, Glorieux G. The middle-molecule hypothesis 30 years after: Lost and rediscovered in the universe of uremic toxicity? J Nephrol. 2008;21:146–160.
   PubMed Web of Science ®Google Scholar
• Vanholder R, van Laecke S, Glorieux G. What is new in uremic toxicity? Pediatr Nephrol. 2008;23:1211–1221.
   PubMed Web of Science ®Google Scholar
• http://eutoxdb.odeesoft.com/index.php
   Google Scholar
• Cohen SS, A Guide to Polyamines. New York: Oxford University Press; 1998.
   Google Scholar
• Tabor CW, Tabor H. It all started on a streetcar in Boston. Annu Rev Biochem. 1999;68:1.
   PubMed Web of Science ®Google Scholar
• Campbell R, Talwalker Y, Bartos D. Polyamines, uremia and hemodialysis. In: Campbell RA, ed. Advances in Polyamine Research. Vol. 2. New York: Raven Press; 1978:319–324.
   Google Scholar
• Saito A, Takagi T, Chung TG, Ohta K. Serum levels of polyamines in patients with chronic renal failure. Kidney Int. 1983;24:234–237.
   Web of Science ®Google Scholar
• Swendseid M, Panaqua M, Kopple JD. Polyamine concentrations in red cells and urine of patients with chronic renal failure. Life Sci. 1980;26:533–539.
   PubMed Web of Science ®Google Scholar
• Igarashi K, Ueda S, Yoshida K, Kashiwagi K. Polyamines in renal failure. Amino Acids. 2006;31:477–483.
   PubMed Web of Science ®Google Scholar
• Sinha-Hikim I, Shen R, Kovacheva E, Crum A, Vaziri ND, Norris KC. Inhibition of apoptotic signaling in spermine-treated vascular muscle cells by a novel glutathione precursor. Cell Biol Int. 2010;34:503–511.
   PubMed Web of Science ®Google Scholar
• Sinha-Hikim I, Shen R, Lee W-NP, et al. Effects of a novel cysteine-based glutathione precursor on oxidative stress in vascular smooth muscle cells. Am J Physiol Cell Physiol. 2010;299:C638–C642.
   Google Scholar
• Igarashi K, Kashiwagi K. Modulation of cellular function by polyamines. Int J Biochem Cell Biol. 2010;42:39–51.
   PubMed Web of Science ®Google Scholar
• Higgins ML, Tillman MC, Rupp JP, Leach FR. The effect of polyamines on cell culture cells. J Cell Physiol. 1969;74:149–154.
   PubMed Web of Science ®Google Scholar
• Gaugas JM, Dewey DL. Evidence for serum binding of oxidized spermine and its potent G1-phase inhibition of cell proliferation. Br J Cancer. 1979;39:548–557.
   PubMed Web of Science ®Google Scholar
• Bachrach U. Oxidized polyamines. Ann N Y Acad Sci. 1970;171:939–956.
   Web of Science ®Google Scholar
• Tabor CW, Tabor H, Bachrach U. Identification of the aminoaldehydes produced by the oxidation of spermine and spermidine with purified plasma amine oxidase. J Biol Chem. 1964;239:2194–2203.
   PubMed Web of Science ®Google Scholar
• Kimes BW, Morris DR. Preparation and stability of oxidized polyamines. Biochim Biophys Acta. 1971;228:223–234.
   PubMed Web of Science ®Google Scholar
• Morgan DM, Bachrach U, Assaraf YG, Harari E, Golenser J. The effect of purified aminoaldehydes produced by polyamine oxidation on the development in vitro of Plasmodium falciparum in normal and glucose-6-phosphate-dehydrogenase-deficient erythrocytes. Biochem J. 1986;236:97–101.
   PubMed Web of Science ®Google Scholar
• Gugliucci A, Lunceford N, Kinugasa E, Ogata H, Schulze J, Kimura S. Acrolein inactivates paraoxonase 1: Changes in free acrolein levels after hemodialysis correlate with increases in paraoxonase 1 activity in chronic renal failure patients. Clin Chim Acta. 2007;384:105–112.
   PubMed Web of Science ®Google Scholar
• Cox PJ. Cyclophosphamide cystitis-identification of acrolein as the causative agent. Biochem Pharmacol. 1979;28:2045–2049.
   PubMed Web of Science ®Google Scholar
• Fujii H, Nishijima F, Goto S. Oral charcoal adsorbent (AST-120) prevents progression of cardiac damage in chronic kidney disease through suppression of oxidative stress. Nephrol Dial Transplant. 2009;24:2089–2095.
   PubMed Web of Science ®Google Scholar
• Liu-Snyder P, McNally H, Shi R, Borgens RB. Acrolein-mediated mechanisms of neuronal death. J Neurosci Res. 2006;84:209–218.
   PubMed Web of Science ®Google Scholar
• Wang L, Sun Y, Asahi M, Otsu K. Acrolein, an environmental toxin, induces cardiomyocyte apoptosis via elevated intracellular calcium and free radicals. Cell Biochem Biophys. 2011;61:131–136.
   PubMed Web of Science ®Google Scholar
• Tanel A, Averill-Bates DA. The aldehyde acrolein induces apoptosis via activation of the mitochondrial pathway. Biochim Biophys Acta. 2005;1743:255–267.
   PubMed Web of Science ®Google Scholar
• Ahmed MSE, Langer H, Abed M, Voelkl J, Lang F. The uremic toxin acrolein promotes suicidal erythrocyte death. Kidney Blood Pres Res. 2013;37:158.
   PubMed Web of Science ®Google Scholar
• Conklin DJ, Barski OA, Lesgards J. Acrolein consumption induces systemic dyslipidemia and lipoprotein modification. Toxicol Appl Pharmacol. 2010;243:1–12.
   PubMed Web of Science ®Google Scholar
• Sakata K, Kashiwagi K, Sharmin S. Acrolein produced from polyamines as one of the uraemic toxins. Biochem Soc Trans. 2003;31:371–374.
   PubMed Web of Science ®Google Scholar
• Sakata K, Kashiwagi K, Sharmin S, et al. Increase in putrescine, amine oxidase, and acrolein in plasma of renal failure patients. Biochem Biophys Res Commun. 2003;305:143–149.
   PubMed Web of Science ®Google Scholar